|
LOC645676 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.546400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.214200E-01 |
| Normal-vs-Stage2 |
8.182400E-01 |
| Normal-vs-Stage3 |
4.247600E-01 |
| Normal-vs-Stage4 |
6.529400E-01 |
| Stage1-vs-Stage2 |
9.204200E-01 |
| Stage1-vs-Stage3 |
3.229800E-01 |
| Stage1-vs-Stage4 |
5.913200E-01 |
| Stage2-vs-Stage3 |
5.749000E-01 |
| Stage2-vs-Stage4 |
5.847600E-01 |
| Stage3-vs-Stage4 |
4.482800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.463800E-01 |
| Normal-vs-AfricanAmerican |
8.286000E-01 |
| Normal-vs-Asian |
6.103900E-03 |
| Caucasian-vs-AfricanAmerican |
8.179400E-01 |
| Caucasian-vs-Asian |
2.403900E-03 |
| AfricanAmerican-vs-Asian |
2.963700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.813400E-01 |
| Normal-vs-Female |
7.988800E-01 |
| Male-vs-Female |
6.559400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.383400E-01 |
| Normal-vs-Extreme_Weight |
9.677800E-01 |
| Normal-vs-Obese |
8.534600E-01 |
| Normal-vs-Extreme_Obese |
3.528000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.478800E-01 |
| Normal_Weight-vs-Obese |
7.635200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.311800E-01 |
| Extreme_Weight-vs-Obese |
7.424600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.940220E-01 |
| Obese-vs-Extreme_Obese |
3.419400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.313800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.365600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.910800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.329830E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.864800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.361600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.337780E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.277800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.181900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.318000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.005400E-01 |
| Normal-VS-Type2 PRCC |
3.715000E-01 |
| Normal-VS-KIRP CIMP |
8.413600E-01 |
| Normal-VS-Unclassified PRCC |
8.948800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.897800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.877000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.457000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.195400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.142200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.677800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.787800E-01 |
| Normal-vs-N1 |
9.377800E-01 |
| Normal-vs-N2 |
8.077600E-01 |
| N0-vs-N1 |
4.599000E-01 |
| N0-vs-N2 |
2.861200E-01 |
| N1-vs-N2 |
9.014400E-01 |
|
|
